G Squared Equity Management L.P. is an investment adviser whose affiliates have sponsored two SPACs: G Squared Ascend I Inc. (NYSE:GSQD) and G Squared Ascend II Inc. (NYSE:GSQB). In dual IPOs last year, the blank-check companies raised $300,000,000 and $125,000,000, respectively, on the promise that their shared management team–which also manages G Squared Equity Management–would conduct a diligent search for attractive acquisition targets in the tech industry.
Just a month ago, Arcadia Biosciences, Inc. (NASDAQ:RKDA) was a penny stock in danger of delisting. But over the past three weeks, the stock has delivered a series of one-day gains as high as 31%. Today, it closed up 34% at $2.62 per share, its highest price since last July. What’s driving the rally?
News of a potential ban on Russian oil in the U.S. on Monday led to a rally in nearly every small-cap stock remotely related to oil. The darling of the bunch was Indonesia Energy Corporation Ltd. (NYSEAMERICAN: INDO), which is the latest battleground stock of self-styled retail apes. A month ago, it was hovering around $4.30 per share. Yesterday, it closed at $61.50. Here’s why it won’t cruise at that altitude for long.
Last month around Valentine’s Day, someone fell in love with Datasea, Inc. (NASDAQ:DTSS). The company’s stock price, which had been declining since Jul. 2021, suddenly sprang to life on Feb. 10, 2022. Over the following 12 days, the price rose 81% to $2.64 per share.
Riddle us this: which stock’s price climbed 85% in the past month while every major market index was nosediving? You’re right if you answered Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), which closed down 2% at $7.86 per share last Friday. The greater riddle, however, is what caused the stock’s remarkable run.